J. Sastre-Garriga has received consulting fees and speaking honoraria from BMS, Sanofi, Merck, Janssen, Novartis, and Roche, is scientific director of
Revista de Neurología, receives an honorarium as a member of the editorial committee of
Multiple Sclerosis Journal, and has received research support from Fondo de Investigación en Salud (PI19/00950 and PI22/00750) from Instituto de Salud Carlos III, Spain. A. Vidal-Jordana has received support from contracts Juan Rodes (JR16/00024) and Fondo de Investigación en Salud (PI17/02162 and PI22/01589) from Instituto de Salud Carlos III, Spain, and has received consulting fees and/or speaker honoraria from Roche, Novartis, and Merck. A. Toosy has received speaker honoraria from Biomedia, Sereno Symposia International Foundation, and Bayer, has received meeting expenses from Biogen Idec and Novartis, was the UK PI for 2 clinical trials sponsored by MEDDAY pharmaceutical company (MD1003 in optic neuropathy [MS-ON - NCT02220244] and progressive MS [MS-SPI2 - NCT02936037]), has been supported by grants from the MRC (MR/S026088/1), NIHR BRC (541/CAP/OC/818837), and RoseTrees Trust (A1332 and PGL21/10079), is an associate editor for
Frontiers in Neurology, and is an editorial board member of
Neurology and
Multiple Sclerosis Journal. C. Enzinger has received travel and speaker honoraria from Biogen, Bayer Schering, Merck Serono, Novartis, Shire, Genzyme, and Teva Pharmaceutical Industries Ltd./Sanofi-Aventis; has received research support from Merck Serono, Biogen, and Teva Pharmaceutical Industries Ltd./Sanofi-Aventis; and has served on scientific advisory boards for Bayer Schering, Biogen, Celgene, Merck Serono, Novartis, Roche and Teva Pharmaceutical Industries Ltd./Sanofi-Aventis. C. Granziera is employed by the University Hospital Basel (USB), has received advisory board and consulting fees from Actelion, Genzyme-Sanofi, Novartis, Jannsen, Merck, Teva, GeNeuro, and Hoffmann La Roche, has received speaker honoraria from Genzyme-Sanofi, Novartis, Jannsen, Merck, Teva, GeNeuro, and Hoffmann La Roche, has received research support from Siemens, GeNeuro, Biogen, Novartis, Hoffmann La Roche, the Swiss National Science Foundation (SNSF) grant PP00P3_206151, the Stiftung zur Förderung der gastroenterologischen und allgemeinen klinischen Forschung, and EUROSTAR E!113682 HORIZON2020. J. Frederiksen has served on scientific advisory boards for and has received travel expenses and speaker honoraria from Merck Serono, Sanofi-Aventis, Roche, Novartis, and Chiesi. O. Ciccareli is an NIHR Research Professor (RP-2017-08-ST2-004), has been a member of independent DSMB for Novartis, has received a speaker honorarium from Merck, has contributed to an advisory board for Biogen; receives an honorarium as Deputy Editor of
Neurology, and has received research support from the MS Society of Great Britain and Northern Ireland, the NIHR UCLH Biomedical Research Centre, the Rosetree Trust, the National MS Society, and the NIHR-HTA. M. Filippi is Editor-in-Chief of the
Journal of Neurology, is an Associate Editor of
Human Brain Mapping,
Neurologic Sciences, and
Radiology; has received consulting fees from Alexion, Almirall, Biogen, Merck, Novartis, Roche, and Sanofi, has received speaker honoraria from Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA, has been an advisory board member for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, and Takeda, has provided scientific direction of educational events for Biogen, Merck, Roche, Celgene, Bristol-Myers Squibb, Lilly, Novartis, and Sanofi-Genzyme, and receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla. X. Montalban has received consulting fees (paid to institution) from AbbVie, Actelion, Alexion, Biogen, Bristol Myers Squibb/Celgene, EMD Serono, Genzyme, Hoffmann-La Roche, Immunic, Janssen Pharmaceuticals, MedDay, Merck, Mylan, Nervgen, Novartis, Sandoz, Sanofi Genzyme, Teva, and TG Therapeutics, has received travel expenses for scientific meeting participation (paid to institution) from the National MS Society and the MS International Federation, and has received research support (funded through institution) from Biogen, Bristol Myers Squibb/Celgene, Hoffmann-La Roche, Sanofi Genzyme, Merck, and Novartis. M. Tintoré has received consulting fees, speaker honoraria, and research support from Almirall, Bayer Schering Pharma, Biogen-Idec, Genzyme, Janssen, Merck-Serono, Novartis, Roche, Sanofi-Aventis, Viela Bio and Teva Pharmaceuticals, and has served on data safety monitoring boards for Parexel and UCB Biopharma. D. Pareto has received research grants from Biogen Idec and Fondo de Investigaciones Sanitarias (PI18/00823, PI22/01709), cofunded by the European Union. À. Rovira has served on scientific advisory boards for Novartis, Sanofi-Genzyme, Synthetic MR, Roche, and Biogen, has received speaker honoraria from Bayer, Sanofi-Genzyme, Merck-Serono, Teva Pharmaceutical Industries Ltd, Novartis, Roche, Bristol-Myers, and Biogen, is CMO and cofounder of TensorMedical, and receives research support from Fondo de Investigación en Salud (PI19/00950 and PI22/01589) from Instituto de Salud Carlos III, Spain. The other authors report no relevant disclosures. Go to
Neurology.org/N for full disclosures.